Endogenous angiogenesis inhibitors prevent adaptive capillary growth in left ventricular pressure overload hypertrophy

Annals of Thoracic Surgery

Volumn 94, Issue 5, 2012, Pages 1509-1517

  Nikolova, Andriana ^a   Ablasser, Klemens ^a   Wyler Von Ballmoos, Moritz C ^a   Poutias, Dimitrios ^a   Kaza, Elisabeth ^a   McGowan, Francis X ^a,b   Moses, Marsha A ^a   Del Nido, Pedro J ^a   Friehs, Ingeborg ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOSTATIN; ENDOSTATIN; GELATINASE B; MATRIX METALLOPROTEINASE 9 INHIBITOR; MATRIX METALLOPROTEINASE INHIBITOR; TUMSTATIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CAPILLARY DENSITY; CAPILLARY PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE OVERLOAD; IMMUNOBLOTTING; NONHUMAN; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; TRANSTHORACIC ECHOCARDIOGRAPHY; ZYMOGRAPHY;

ANGIOSTATINS; ANIMALS; AUTOANTIGENS; COLLAGEN TYPE IV; ENDOSTATINS; HYPERTROPHY, LEFT VENTRICULAR; MATRIX METALLOPROTEINASE 9; NEOVASCULARIZATION, PHYSIOLOGIC; PRESSURE; RABBITS;

EID: 84867796103     PISSN: 00034975     EISSN: 15526259     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2012.05.052     Document Type: Article

References (40)

1. R. Timpl Molecular aspects of the basement membrane structure Prog Clin Biol Res 171 1985 63 74
2. E. Lundgren, D. Gullberg, K. Rubin, T.K. Borg, M.J. Terracio, L. Terracio In vitro studies on adult cardiac myocytes: attachment and biosynthesis of collagen type IV and laminin J Cell Physiol 136 1988 43 53
3. E.I. Deryugina, J.P. Quigley Matrix metalloproteinases and tumor metastasis Cancer Metastasis Rev 25 2006 9 34
4. I. Friehs, R. Margossian, A.M. Moran, H. Cao-Danh, M.A. Moses, P.J. del Nido Vascular endothelial growth factor delays onset of failure in pressure-overload hypertrophy through matrix metalloproteinase activation and angiogenesis Basic Res Cardiol 100 2005 1 10
5. F.F. Mohammed, D.S. Smookler, R. Khokha Metalloproteinases, inflammation, and rheumatoid arthritis Ann Rheum Dis 62 Suppl 2 2003 ii43 ii47
6. C.M. Dollery, J.R. McEwan, A.M. Henney Matrix metalloproteinases and cardiovascular disease Circ Res 77 1995 863 868
7. M.L. Lindsey, G.P. Escobar, L.W. Dobrucki Matrix metalloproteinase-9 gene deletion facilitates angiogenesis after myocardial infarction Am J Physiol Heart Circ 290 2006 H232 H239
8. T.H. Vu, Z. Werb Matrix metalloproteinases: effectors of development and normal physiology Genes Dev 14 2000 2123 2133
9. M. Franz, A. Berndt, A. Altendorf-Hofmann Serum levels of large tenascin-C variants, matrix metalloproteinase-9, and tissue inhibitors of matrix metalloproteinases in concentric versus eccentric left ventricular hypertrophy Eur J Heart Fail 11 2009 1057 1062
10. L.A. Cornelius, L.C. Nehring, E. Harding Matrix metalloproteinases generate angiostatin: effects on neovascularization J Immunol 161 1998 6845 6852
11. C. Bendrik, J. Robertson, J. Gauldie, C. Dabrosin Gene transfer of matrix metalloproteinase-9 induces tumor regression of breast cancer in vivo Cancer Res 68 2008 3405 3412
12. V.R. Panchal, J. Rehman, A.T. Nguyen Reduced pericardial levels of endostatin correlate with collateral development in patients with ischemic heart disease J Am Coll Cardiol 43 2004 1383 1387
13. Y. Hamano, M. Zeisberg, H. Sugimoto Physiological levels of tumstatin, a fragment of collagen IV alpha3 chain, are generated by MMP-9 proteolysis and suppress angiogenesis via alphaV beta3 integrin Cancer Cell 3 2003 589 601
14. S.C. Tyagi, S.G. Kumar, S.J. Haas Post-transcriptional regulation of extracellular matrix metalloproteinase in human heart end-stage failure secondary to ischemic cardiomyopathy J Mol Cell Cardiol 28 1996 1415 1428
15. A.M. Moran, I. Friehs, K. Takeuchi Noninvasive serial evaluation of myocardial mechanics in pressure overload hypertrophy of rabbit myocardium Herz 28 2003 52 62
16. I. Friehs, R. Barillas, N.V. Vasilyev, N. Roy, F.X. McGowan, P.J. del Nido Vascular endothelial growth factor (VEGF) prevents apoptosis and preserves contractile function in hypertrophied infant heart Circulation 114 Suppl I 2006 I290 I295
17. I. Friehs, H. Cao-Danh, M. Nathan, F.X. McGowan, P.J. del Nido Impaired insulin-signaling in hypertrophied hearts contributes to increased susceptibility to ischemic injury Biochem Biophys Res Commun 331 2005 15 22
18. I. Friehs, A.M. Moran, C. Stamm Promoting angiogenesis protects severely hypertrophied hearts from ischemic injury Ann Thorac Surg 77 2004 2004 2011
19. K. Brew, D. Dinakarpandian, H. Nagase Tissue inhibitors of metalloproteinases: evolution, structure and function Biochim Biophys Acta 1477 2000 267 283
20. Y.Y. Li, C.F. McTiernan, A.M. Feldman Proinflammatory cytokines regulate tissue inhibitors of metalloproteinases and disintegrin metalloproteinase in cardiac cells Cardiovasc Res 42 1999 162 172
21. W.S. Bradham, B. Bozkurt, H. Gunasinghe, D. Mann, F.G. Spinale Tumor necrosis factor-alpha and myocardial remodeling in progression of heart failure: a current perspective Cardiovasc Res 53 2002 822 830
22. Y.Y. Li, Y. Feng, C.F. McTiernan Downregulation of matrix metalloproteinases and reduction in collagen damage in the failing human heart after support with left ventricular assist devices Circulation 104 2001 1147 1152
23. C. Stamm, I. Friehs, D.B. Cowan Inhibition of tumor necrosis factor-alpha improves postischemic recovery of hypertrophied hearts Circulation 104 12 Suppl 1 2001 I350 I355
24. K.K. Linask, M. Han, D.H. Cai, P.R. Brauer, S.M. Maisastry Cardiac morphogenesis: matrix metalloproteinase coordination of cellular mechanisms underlying heart tube formation and directionality of looping Dev Dyn 233 2005 739 753
25. T. Itoh, T. Ikeda, H. Gomi, S. Nakao, T. Suzuki, S. Itohara Unaltered secretion of beta-amyloid precursor protein in gelatinase A (matrix metalloproteinase 2)-deficient mice J Biol Chem 272 1997 22389 22392
26. Y.Y. Li, A.M. Feldman, Y. Sun, C.F. McTiernan Differential expression of tissue inhibitors of metalloproteinases in the failing human heart Circulation 98 1998 1728 1734
27. S. Uemura, H. Matsushita, W. Li Diabetes mellitus enhances vascular matrix metalloproteinase activity: role of oxidative stress Circ Res 88 2001 1291 1298
28. A. Ducharme, S. Frantz, M. Aikawa Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction J Clin Invest 106 2000 55 62
29. G.R. Martin, R. Timpl Laminin and other basement membrane components Annu Rev Cell Biol 3 1987 57 85
30. O. Menzel, R.C. Bekkeheien, A. Reymond Knobloch syndrome: novel mutations in COL18A1, evidence for genetic heterogeneity, and a functionally impaired polymorphism in endostatin Hum Mutat 23 2004 77 84
31. M. Dhanabal, R. Ramchandran, M.J. Waterman Endostatin induces endothelial cell apoptosis J Biol Chem 274 1999 11721 11726
32. J. Dixelius, M. Cross, T. Matsumoto, T. Sasaki, R. Timpl, L. Claesson-Welsh Endostatin regulates endothelial cell adhesion and cytoskeletal organization Cancer Res 62 2002 1944 1947
33. A.M. Romanic, S.M. Harrison, W. Bao Myocardial protection from ischemia/reperfusion injury by targeted deletion of matrix metalloproteinase-9 Cardiovasc Res 54 2002 549 558
34. Y.M. Kim, J.W. Jang, O.H. Lee Endostatin inhibits endothelial and tumor cellular invasion by blocking the activation and catalytic activity of matrix metalloproteinase Cancer Res 60 2000 5410 5413
35. Y.M. Kim, S. Hwang, B.J. Pyun Endostatin blocks vascular endothelial growth factor-mediated signaling via direct interaction with KDR/Flk-1 J Biol Chem 277 2002 27872 27879
36. N.R. Sodha, R.T. Clements, M. Boodhwani Endostatin and angiostatin are increased in diabetic patients with coronary artery disease and associated with impaired coronary collateral formation Am J Physiol Heart Circ Physiol 296 2009 H428 H434
37. E. Toyota, T. Matsunaga, W.M. Chilian Myocardial angiogenesis Mol Cell Biochem 264 2004 35 44
38. Y. Maeshima, P.C. Colorado, A. Torre Distinct antitumor properties of a type IV collagen domain derived from basement membrane J Biol Chem 275 2000 21340 21348
39. L.M. Golub, H.M. Lee, M.E. Ryan, W.V. Giannobile, J. Payne, T. Sorsa Tetracyclines inhibit connective tissue breakdown by multiple non-antimicrobial mechanisms Adv Dent Res 12 1998 12 26
40. E. Kaza, K. Ablasser, D. Poutias Up-regulation of soluble vascular endothelial growth factor receptor-1 prevents angiogenesis in hypertrophied myocardium Cardiovasc Res 89 2011 410 418